SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharma gains on plan to raise $500 million

29 Dec 2015 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 926.80, up by 2.55 points or 0.28% from its previous closing of Rs. 924.25 on the BSE.

The scrip opened at Rs. 927.00 and has touched a high and low of Rs. 930.90 and Rs. 925.20 respectively. So far 8828 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 703.50 on 07-Jan-2015.

Last one week high and low of the scrip stood at Rs. 957.80 and Rs. 917.00 respectively. The current market cap of the company is Rs. 26170.17 crore.

The promoters holding in the company stood at 46.45% while Institutions and Non-Institutions held 42.81% and 10.75% respectively.

Glenmark Pharmaceuticals is seeking shareholders’ approval to raise up to $500 million (around Rs 3,300 crore) by issue of securities in domestic and international markets.

In order to capitalise on various opportunities for further growth of the business, the company intends to enhance its marketing network both in domestic and overseas market, set up manufacturing infrastructure, focus on R&D and introduce new products across various markets.

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×